Amy Pai Elected ACCP Research Institute Trustee
Amy Barton Pai, PharmD, FASN, FCCP, FNKF, associate professor of clinical pharmacy at the University of Michigan College of Pharmacy, has been elected to a Board of Trustees position with the American College of Clinical Pharmacy’s (ACCP) Research Institute.
The ACCP is a pharmacy professional association representing the interests of clinical pharmacists. Its Research Institute (RI) is a non-profit, charitable foundation, whose goal is to improve human health by extending the frontiers of clinical pharmacy.
As part of their leadership responsibilities, Dr. Pai will lend her intellectual, scientific perspective and vision, to the Research Institute. She will help to develop strategic plans and policies to conduct Research Institute initiatives and guide future growth that include identifying, prioritizing, and implementing research and education agendas and programs, and guiding fundraising efforts for the institute.
“I am honored to serve as a RI Trustee,” says Dr. Pai. “I can say confidently that funding from ACCP early in my career was the springboard for development of my research program. My ultimate goal as a RI Trustee is to leverage my unique experiences with research partnerships and traditional, as well as non-traditional, funding sources to support initiatives that will augment the strategic RI Strategic Plan.”
Dr. Pai earned a Bachelor of Science in Pharmacy from Albany College of Pharmacy (ACP) and completed a Pharmacy Practice Residency at St. Peter’s Hospital in Albany, New York. After receiving her Doctor of Pharmacy from ACP in 1999, she completed a Nephrology Research Fellow at the University of Illinois at Chicago. Dr. Pai was on faculty at the University of New Mexico College of Pharmacy from 2001 to 2008 and at Albany College of Pharmacy and Health Sciences from 2008 to 2016. She recently completed a Master’s degree in Healthcare Innovation at Arizona State University. Dr. Pai’s research program conducts studies across the clinical and translational continuum. Her research includes toxicity evaluation of intravenous iron formulations, reducing preventable harm from NSAIDs and evaluating innovative models for medication management in dialysis patients.
A member of ACCP since 1999 and a fellow since 2010, Dr. Pai has been continually active in the organization serving as Nephrology PRN Chair, President of the New York State Chapter of ACCP and a reviewer for BCACP and PSAP. Currently, she a representative for ACCP to the Kidney Health Initiative, a partnership between the FDA and American Society of Nephrology.